Changes in cartilage composition and physical properties due to stromelysin degradation
Open Access
- 1 February 1995
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 38 (2), 173-183
- https://doi.org/10.1002/art.1780380205
Abstract
Objective. To determine the effects of stromelysin treatment on biochemical, histologic, and swelling characteristics of intact cartilage explants and to correlate these effects with changes in the functional physical properties of the tissue. Methods. Bovine articular cartilage explants were cultured for up to 3 days in the presence or absence of recombinant human stromelysin (SLN). Damage to matrix proteoglycans and collagens was assessed and characterized by N-terminal sequencing and Western blot analysis, respectively. Explants were mechanically tested to assess the ability of the tissue to withstand cyclic and static compressive loads. Results. Treatment with SLN resulted in a time-and dose-dependent loss of proteoglycans from cartilage explants, with significant loss seen after 3 days of exposure to 20 nM SLN. Histology indicated that initial loss of proteoglycans occurred in regions near the tissue surface and proceeded inward with increasing time of SLN exposure. SLN treatment resulted in degradation of matrix collagen types IX and II, and a concomitant increase in tissue swelling. This matrix degradation resulted in severe alterations in functional physical properties of the tissue, including compressive stiffness. The initial, focal loss of proteoglycans that resulted from SLN treatment was most accurately detected with highfrequency streaming potential measurements. Conclusion. Exposure of intact cartilage to SLN caused specific, molecular-level degradation of matrix molecules, which resulted in changes in the swelling behavior and marked deterioration of functional physical properties of the tissue.This publication has 48 references indexed in Scilit:
- Abnormality of type IX collagen in a patient with diastrophic dysplasiaAmerican Journal of Medical Genetics, 1994
- Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin b and an inhibitor of matrix metalloproteinases. evidence for two converging pathways of chondrocyte‐mediated proteoglycan degradationArthritis & Rheumatism, 1993
- Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritisArthritis & Rheumatism, 1993
- Detection of Stromelysin and Collagenase in Synovial Fluid From Patients with Rheumatoid Arthritis and Posttraumatic Knee InjuryArthritis & Rheumatism, 1992
- Heat shock of rabbit synovial fibroblasts increases expression of mRNAs for two metalloproteinases, collagenase and stromelysin.The Journal of cell biology, 1989
- Canine osteoarthritis: Effects of endogenous neutral metalloproteoglycanases on articular cartilage proteoglycansJournal of Orthopaedic Research, 1988
- Collagen type IX: Evidence for covalent linkages to type II collagen in cartilageFEBS Letters, 1987
- Streaming potentials: A sensitive index of enzymatic degradation in articular cartilageJournal of Orthopaedic Research, 1987
- Improved cartilage fixation by ruthenium hexammine trichloride (RHT): A prerequisite for morphometry in growth cartilageJournal of Ultrastructure Research, 1982
- Flow-independent viscoelastic properties of articular cartilage matrixJournal of Biomechanics, 1978